EA201992577A1 - 5,6-CONDENSED Bicyclic Compounds and Compositions for the Treatment of Parasitic Diseases - Google Patents
5,6-CONDENSED Bicyclic Compounds and Compositions for the Treatment of Parasitic DiseasesInfo
- Publication number
- EA201992577A1 EA201992577A1 EA201992577A EA201992577A EA201992577A1 EA 201992577 A1 EA201992577 A1 EA 201992577A1 EA 201992577 A EA201992577 A EA 201992577A EA 201992577 A EA201992577 A EA 201992577A EA 201992577 A1 EA201992577 A1 EA 201992577A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- treatment
- parasitic diseases
- bicyclic compounds
- condensed bicyclic
- Prior art date
Links
- 208000030852 Parasitic disease Diseases 0.000 title 1
- 125000002619 bicyclic group Chemical group 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
В настоящем изобретении представлены соединение формулы (I) или его фармацевтически приемлемая сольспособ получения соединений по настоящему изобретению и пути их терапевтического применения. В настоящем изобретении дополнительно представлена комбинация фармакологически активных средств и фармацевтическая композиция.The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt method for preparing the compounds of the present invention and their therapeutic use. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762581919P | 2017-11-06 | 2017-11-06 | |
PCT/IB2018/053818 WO2018220531A1 (en) | 2017-05-31 | 2018-05-29 | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201992577A1 true EA201992577A1 (en) | 2020-03-30 |
EA039324B1 EA039324B1 (en) | 2022-01-13 |
Family
ID=80685588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201992577A EA039324B1 (en) | 2017-11-06 | 2018-05-29 | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA039324B1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS58053B1 (en) * | 2013-12-19 | 2019-02-28 | Novartis Ag | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis |
EP3303336A1 (en) * | 2015-05-29 | 2018-04-11 | GlaxoSmithKline Intellectual Property Development Limited | Imidazo[1,2-b][1,2,4]triazine derivatives as antiparasitic agents |
BR112018002597B1 (en) * | 2015-08-07 | 2020-09-24 | University Of Dundee | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND COMBINATION CONTAINING THESE COMPOUNDS AND USE OF THE SAME TO PREVENT OR TREAT CHAGAS DISEASE, AFRICAN HUMAN TRIPANOSOMIASIS, AFRICAN ANIMAL TRYPANOSOMIASIS AND LEISHMANIOSIS |
-
2018
- 2018-05-29 EA EA201992577A patent/EA039324B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA039324B1 (en) | 2022-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119490T1 (en) | PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT | |
EA201592256A1 (en) | DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES | |
EA202090688A1 (en) | BIS-AMIDE CONNECTIONS ACTIVATING SARCOMER AND VARIANTS OF THEIR APPLICATION | |
EA201692542A1 (en) | INDANEOUS AND INDOLINE DERIVATIVES AND THEIR APPLICATION AS ACTIVATORS OF SOLUBLE GUANYLATSYCLASES | |
CY1124251T1 (en) | CARBOXAMIDE DERIVATIVES | |
EA201990765A1 (en) | AZAINDAZOLE COMPOUNDS FOR USE IN DAMAGE OF THE TENDON AND / OR Ligaments | |
EA201692298A1 (en) | DERIVATIVES OF CARBOXAMIDES | |
PH12019500849A1 (en) | Naphthyridinone derivatives and their use inthe treatment of arrhythmia | |
PH12019502652A1 (en) | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases | |
CY1124301T1 (en) | INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES | |
EA201691058A1 (en) | DERIVATIVES OF PYRROLOPIRROLON AND THEIR APPLICATION FOR THE TREATMENT OF DISEASES | |
EA202190316A1 (en) | CONDENSED LACTAM DERIVATIVE | |
EA202091293A1 (en) | PYRIDINONE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | |
EA201992577A1 (en) | 5,6-CONDENSED Bicyclic Compounds and Compositions for the Treatment of Parasitic Diseases | |
EA202192760A1 (en) | TRICYCLIC COMPOUNDS | |
ZA202204251B (en) | Compounds and compositions for the treatment of parasitic diseases | |
EA201991008A1 (en) | NEW DERIVATIVES OF NAFTIRIDINONE AND THEIR APPLICATION IN TREATMENT OF ARRHYTHMIA | |
EA202090644A1 (en) | IMIDAZO DERIVATIVES [1,5-a] PYRASINE AS PI3K INHIBITORS | |
EA202192382A1 (en) | COMPOUNDS TARGETING PRMT5 | |
EA202190689A1 (en) | QUINOLINE DERIVATIVES AS INTEGRIN ALPHA4BETA7 INHIBITORS |